As an antidiabetic drug of DPP-4 inhibitor, the marketing of Tregliptin in China is the focus of attention of diabetes patients. According to t...
Trelagliptin, as a long-acting DPP-4 inhibitor, has the characteristics of both fixed and flexible medication time. It is necessary to arrange ...
Treagliptin is a long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor, which is mainly used for the treatment of type 2 diabetes. It has the co...
Tregliptin is a long-acting DPP-4 inhibitor, which is used for the treatment of type 2 diabetes. It is necessary to pay attention to the key in...
Larotrectinib has been launched in China and is suitable for NTRK gene fusion positive solid tumor patients. The product name is "Vitrakvi" and...
Larotrectinib, as a broad-spectrum anti-cancer targeted drug with NTRK gene fusion positivity, has been clinically studied to have significant ...
Larotrectinib has been launched in China and is suitable for solid tumor patients with NTRK gene fusion positivity. When using it, attention sh...
Larotrectinib should be taken as a whole tablet, and the recommended dosage should be adjusted according to age and weight. It can be taken wit...
Esbriet is recommended to be taken with meals to reduce the risk of gastrointestinal adverse reactions. It should be administered three times a...
Ongentys is a COMT inhibitor used for the treatment of Parkinson's disease, and special attention should be paid to drug interactions, neurolog...